Hyderabad: Dr. Reddy&Rsquo;S Laboratories Ltd, Along With Its Subsidiaries Together Referred To As &Ldquo;Dr. Reddy&Rsquo;S&Rdquo; Today Announced The Launch Of Avigan&Reg; (Favipiravir) 200 Mg Tablets In India.The Launch Is Part Of The Global Licensing Agreement With Fujifilm Toyama Chemical Co. Ltd. That Grants Dr. Reddy&Rsquo;S The Exclusive Rights To Manufacture, Sell And Distribute Avigan (Favipiravir) 200 Mg Tablets In India.Avigan&Reg; (Favipiravir) Has Been Approved By The Drugs Controller General Of India (Dcgi) For The Treatment Of Patients With Mild To Moderate Covid-19 Disease.
